Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafah Salloum

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|May 18, 2011
Interferon regulatory factors in human lupus pathogenesisRafah Salloum, Timothy B Niewold
Journal of Biomedicine & Biotechnology|July 24, 2010
Interferon alpha in systemic lupus erythematosusTimothy B Niewold, Daniel N Clark, Rafah Salloum, et al.
Cureus|January 25, 2021
Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?Mohsin S Mughal, Ikwinder Kaur, Mili Kakadia, et al.
Expert Opinion on Biological Therapy|May 26, 2009
Ocrelizumab: a step forward in the evolution of B-cell therapyFariha Kausar, Khader Mustafa, Ghaleb Sweis, et al.
Arthritis and Rheumatism|January 30, 2010
Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patientsRafah Salloum, Beverly S Franek, Silvia N Kariuki, et al.
Plos One|February 9, 2010
Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestationsNadera J Sweiss, Rafah Salloum, Seema Gandhi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Translational Research : the Journal of Laboratory and Clinical Medicine|May 18, 2011
Interferon regulatory factors in human lupus pathogenesisRafah Salloum, Timothy B Niewold
Journal of Biomedicine & Biotechnology|July 24, 2010
Interferon alpha in systemic lupus erythematosusTimothy B Niewold, Daniel N Clark, Rafah Salloum, et al.
Cureus|January 25, 2021
Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?Mohsin S Mughal, Ikwinder Kaur, Mili Kakadia, et al.
Expert Opinion on Biological Therapy|May 26, 2009
Ocrelizumab: a step forward in the evolution of B-cell therapyFariha Kausar, Khader Mustafa, Ghaleb Sweis, et al.
Arthritis and Rheumatism|January 30, 2010
Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patientsRafah Salloum, Beverly S Franek, Silvia N Kariuki, et al.
Plos One|February 9, 2010
Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestationsNadera J Sweiss, Rafah Salloum, Seema Gandhi, et al.
Pageof 1